Cell Biotech Co Ltd
KOSDAQ:049960
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cell Biotech Co Ltd
Cash from Operating Activities
Cell Biotech Co Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cell Biotech Co Ltd
KOSDAQ:049960
|
Cash from Operating Activities
₩11.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-5%
|
|
|
Celltrion Inc
KRX:068270
|
Cash from Operating Activities
₩646.1B
|
CAGR 3-Years
808%
|
CAGR 5-Years
13%
|
CAGR 10-Years
27%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Cash from Operating Activities
₩102.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Cash from Operating Activities
-₩29.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Cash from Operating Activities
₩124.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
137%
|
CAGR 10-Years
49%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Cash from Operating Activities
-₩41.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Cell Biotech Co Ltd
Glance View
Cell Biotech Co., Ltd. engages in the manufacture, research and development of probiotics lactobacillus products. The company is headquartered in Gimpo, Gyeonggi-Do. The company went IPO on 2002-12-13. The firm's products include lactic acid bacteria (LAB) powders and finished products containing LABs. Its LAB powders are used as raw materials in foods and medicines for the functions of immunization enhancement and digestion improvement. Its finished products containing LABs are used for intestinal health improvement, carcinogen inhibition, calcium supplement and others. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Cell Biotech Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
11.1B
KRW
Based on the financial report for Dec 31, 2025, Cell Biotech Co Ltd's Cash from Operating Activities amounts to 11.1B KRW.
What is Cell Biotech Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-5%
Over the last year, the Cash from Operating Activities growth was -42%. The average annual Cash from Operating Activities growth rates for Cell Biotech Co Ltd have been -5% over the past three years , 3% over the past five years , and -5% over the past ten years .
